Tailor an Options Trading Strategy to Fit Your Needs
This guide will help you identify and execute an options trading strategy that fits your specific needs and risk profile.

Take your trading to the next level with the Options Strategy Guide.
Download your FREE Options Strategy Guide Today.

AVTX Insider Trading (Avalo Therapeutics)

Insider Ownership Percentage: 45.70%
Insider Buying (Last 12 Months): $1,573,602.52
Insider Selling (Last 12 Months): $0.00

Avalo Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Avalo Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Avalo Therapeutics Share Price & Price History

Current Price: $0.52
Price Change: Price Increase of +0.02 (4.00%)
As of 07/1/2022 04:59 PM ET

This chart shows the closing price history over time for AVTX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
27 U.S. Cities Where Stocks Yield 26% a Year
What’s the highest-yielding stock you’ve ever owned? The dividends for these stocks have risen so fast over the years that they’re now yielding us an average of 26%!

When you start getting paid 26% on your money, your financial problems tend to pretty much evaporate.
Get in on the action here.

Avalo Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/14/2022Armistice Capital, LlcDirectorBuy100,000$0.65$65,000.00View SEC Filing Icon  
3/10/2022Armistice Capital, LlcDirectorBuy26,000$0.70$18,200.00View SEC Filing Icon  
3/7/2022Armistice Capital, LlcDirectorBuy325,000$0.66$214,500.00View SEC Filing Icon  
3/3/2022Armistice Capital, LlcDirectorBuy50,000$0.71$35,500.00View SEC Filing Icon  
2/24/2022Armistice Capital, LlcDirectorBuy100,000$0.80$80,000.00View SEC Filing Icon  
2/22/2022Armistice Capital, LlcDirectorBuy83,000$0.77$63,910.00View SEC Filing Icon  
2/17/2022Armistice Capital, LlcDirectorBuy150,000$0.81$121,500.00View SEC Filing Icon  
1/20/2022Armistice Capital, LlcDirectorBuy12,000$0.85$10,200.00View SEC Filing Icon  
1/18/2022Armistice Capital, LlcDirectorBuy206,300$0.88$181,544.00View SEC Filing Icon  
1/14/2022Armistice Capital, LlcDirectorBuy85,000$0.93$79,050.00View SEC Filing Icon  
1/12/2022Armistice Capital, LlcDirectorBuy57,300$1.04$59,592.00View SEC Filing Icon  
1/10/2022Armistice Capital, LlcDirectorBuy491,097$0.99$486,186.03View SEC Filing Icon  
1/7/2022Armistice Capital, LlcDirectorBuy137,900$1.04$143,416.00View SEC Filing Icon  
12/10/2021Christopher Ryan SullivanCAOBuy955$1.57$1,499.35View SEC Filing Icon  
12/10/2021H. Jeffrey WilkinsInsiderBuy6,371$1.57$10,002.47View SEC Filing Icon  
12/10/2021Schond L. GreenwayCFOBuy2,231$1.57$3,502.67View SEC Filing Icon  
See Full Table
Tailor an Options Trading Strategy to Fit Your Needs
This guide will help you identify and execute an options trading strategy that fits your specific needs and risk profile.

Take your trading to the next level with the Options Strategy Guide.
Download your FREE Options Strategy Guide Today.

SEC Filings (Institutional Ownership Changes) for Avalo Therapeutics (NASDAQ:AVTX)

77.15% of Avalo Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at AVTX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Avalo Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/16/2022Goldman Sachs Group Inc.524,884$0.38M0.0%-23.4%0.465%Search for SEC Filing on Google Icon
5/13/2022Renaissance Technologies LLC367,193$0.27M0.0%+819.1%0.326%Search for SEC Filing on Google Icon
5/13/2022Nantahala Capital Management LLC6,849,547$4.80M0.2%-4.1%6.073%Search for SEC Filing on Google Icon
5/12/2022Integral Health Asset Management LLC700,000$0.51M0.1%-56.9%0.621%Search for SEC Filing on Google Icon
5/3/2022Leo Brokerage LLC62,629$45K0.0%N/A0.056%Search for SEC Filing on Google Icon
4/25/2022Assenagon Asset Management S.A.42,338$31K0.0%-92.7%0.038%Search for SEC Filing on Google Icon
2/15/2022Stonepine Capital Management LLC1,510,095$2.57M1.2%+77.7%1.344%Search for SEC Filing on Google Icon
2/15/2022LGL Partners LLC28,850$49K0.0%N/A0.026%Search for SEC Filing on Google Icon
2/14/2022Freestone Capital Holdings LLC20,000$34K0.0%N/A0.018%Search for SEC Filing on Google Icon
2/14/2022Soleus Capital Management L.P.770,000$1.31M0.1%N/A0.686%Search for SEC Filing on Google Icon
2/8/2022Northern Trust Corp533,578$0.91M0.0%+3.1%0.475%Search for SEC Filing on Google Icon
2/1/2022Assenagon Asset Management S.A.582,718$0.99M0.0%-33.7%0.519%Search for SEC Filing on Google Icon
1/24/2022Strs Ohio38,400$65K0.0%-40.2%0.034%Search for SEC Filing on Google Icon
1/20/2022Minot Wealth Management LLC34,645$59K0.0%-66.5%0.031%Search for SEC Filing on Google Icon
12/29/2021Hudson Bay Capital Management LP197,133$0.43M0.0%N/A0.176%Search for SEC Filing on Google Icon
11/16/2021Opaleye Management Inc.1,459,400$3.18M0.6%N/A1.299%Search for SEC Filing on Google Icon
11/16/2021Squarepoint Ops LLC18,657$41K0.0%N/A0.017%Search for SEC Filing on Google Icon
11/16/2021Two Sigma Advisers LP801,300$1.75M0.0%N/A0.713%Search for SEC Filing on Google Icon
11/16/2021Two Sigma Investments LP732,931$1.60M0.0%N/A0.653%Search for SEC Filing on Google Icon
11/16/2021Laurion Capital Management LP330,444$0.72M0.0%N/A0.294%Search for SEC Filing on Google Icon
11/15/2021Point72 Asset Management L.P.6,008,850$13.10M0.1%N/A5.350%Search for SEC Filing on Google Icon
11/15/2021Atom Investors LP27,507$60K0.0%N/A0.024%Search for SEC Filing on Google Icon
11/15/2021Voya Investment Management LLC21,854$48K0.0%N/A0.019%Search for SEC Filing on Google Icon
11/15/2021Caas Capital Management LP11,812$26K0.0%N/A0.011%Search for SEC Filing on Google Icon
11/12/2021Aristides Capital LLC48,953$0.11M0.0%N/A0.044%Search for SEC Filing on Google Icon
11/12/2021Stonepine Capital Management LLC850,000$1.85M0.8%N/A0.770%Search for SEC Filing on Google Icon
11/12/2021Geode Capital Management LLC1,242,382$2.71M0.0%N/A1.126%Search for SEC Filing on Google Icon
11/12/2021Integral Health Asset Management LLC1,625,000$3.54M1.0%N/A1.473%Search for SEC Filing on Google Icon
11/10/2021Goldman Sachs Group Inc.672,664$1.47M0.0%N/A0.610%Search for SEC Filing on Google Icon
11/10/2021Creative Planning14,814$32K0.0%N/A0.013%Search for SEC Filing on Google Icon
11/10/2021Alliancebernstein L.P.19,100$42K0.0%N/A0.017%Search for SEC Filing on Google Icon
11/9/2021BlackRock Inc.3,716,943$8.10M0.0%N/A3.369%Search for SEC Filing on Google Icon
11/9/2021Monashee Investment Management LLC270,000$0.59M0.1%N/A0.245%Search for SEC Filing on Google Icon
11/8/2021Meeder Asset Management Inc.19,260$43K0.0%N/A0.017%Search for SEC Filing on Google Icon
11/4/2021Asymmetry Capital Management L.P.534,621$1.17M0.7%N/A0.485%Search for SEC Filing on Google Icon
11/4/2021Deutsche Bank AG31,794$69K0.0%N/A0.029%Search for SEC Filing on Google Icon
11/2/2021Cambridge Investment Research Advisors Inc.12,164$27K0.0%N/A0.011%Search for SEC Filing on Google Icon
11/2/2021New York State Common Retirement Fund22,214$48K0.0%N/A0.020%Search for SEC Filing on Google Icon
11/2/2021Victory Capital Management Inc.15,788$34K0.0%N/A0.014%Search for SEC Filing on Google Icon
11/1/2021SG Americas Securities LLC18,596$41K0.0%N/A0.017%Search for SEC Filing on Google Icon
10/29/2021Commonwealth Equity Services LLC52,000$0.11M0.0%N/A0.047%Search for SEC Filing on Google Icon
10/25/2021Minot Wealth Management LLC103,410$0.23M0.0%N/A0.094%Search for SEC Filing on Google Icon
10/22/2021Strs Ohio64,200$0.14M0.0%N/A0.058%Search for SEC Filing on Google Icon
10/19/2021Assenagon Asset Management S.A.879,334$1.92M0.0%N/A0.797%Search for SEC Filing on Google Icon
10/19/2021Tamar Securities LLC23,084$50K0.0%N/A0.021%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Avalo Therapeutics logo
Avalo Therapeutics, Inc., a clinical-stage precision medicine company, discovers, develops, and commercializes targeted therapeutics for patients with unmet clinical need in immunology, immuno-oncology, and rare genetic diseases. It develops AVTX-002, a fully human anti-LIGHT monoclonal antibody, which is under Phase II clinical trial for the treatment of non-eosinophilic asthma, as well as inflammatory bowel disease, including moderate to severe Crohn's disease, and ulcerative colitis; and Phase III clinical trial for the treatment of COVID-19 acute respiratory distress syndrome. The company also engages in developing AVTX-007, a fully human Anti-IL-18 monoclonal antibody that is under Phase I clinical trial for the treatment of still's disease, including adult-onset still's disease and systemic juvenile idiopathic arthritis. Its products for rare genetic diseases in Phase III clinical trials include AVTX-801, a D-galactose substrate replacement therapy for the treatment of phosphoglucomutase 1 deficiency (PGM1), also known as PGM1-CDG; and AVTX-803, a L-fucose substrate replacement therapy for the treatment of LADII, also known as SLC35C1-CDG. The company was formerly known as Cerecor Inc. and changed its name to Avalo Therapeutics, Inc. in August 2021. Avalo Therapeutics, Inc. was incorporated in 2011 and is headquartered in Rockville, Maryland.
Read More on Avalo Therapeutics

Today's Range

Now: $0.52
Low: $0.50
High: $0.52

50 Day Range

MA: $0.40
Low: $0.25
High: $0.56

52 Week Range

Now: $0.52
Low: $0.20
High: $3.43

Volume

801 shs

Average Volume

550,183 shs

Market Capitalization

$58.65 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.76

Who are the company insiders with the largest holdings of Avalo Therapeutics?

Avalo Therapeutics' top insider shareholders include:
  1. Armistice Capital, Llc (Director)
  2. Christopher Ryan Sullivan (CAO)
  3. H Jeffrey Wilkins (Insider)
  4. Schond L Greenway (CFO)
Learn More about top insider investors at Avalo Therapeutics.
27 U.S. Cities Where Stocks Yield 26% a Year
What’s the highest-yielding stock you’ve ever owned? The dividends for these stocks have risen so fast over the years that they’re now yielding us an average of 26%!

When you start getting paid 26% on your money, your financial problems tend to pretty much evaporate.
Get in on the action here.